Successful treatment with doripenem of ventriculitis due to Achromobacter xylosoxidans

QJM: An International Journal of Medicine

Volumn 107, Issue 11, 2014, Pages 923-925

  Gelfand, M S ^a   Cleveland, K O ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLAVULANIC ACID; DORIPENEM; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; TICARCILLIN; TIGECYCLINE; TOBRAMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ACHROMOBACTER XYLOSOXIDANS; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BRAIN VENTRICLE PERITONEUM SHUNT; BRAIN VENTRICULITIS; CASE REPORT; CEREBROSPINAL FLUID CULTURE; CHRONOTHERAPY; DEVICE REMOVAL; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG SUBSTITUTION; FEMALE; GENERAL CONDITION IMPROVEMENT; HUMAN; LENGTH OF STAY; MINIMUM INHIBITORY CONCENTRATION; MYOCLONUS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SEIZURE; SINGLE DRUG DOSE; ACHROMOBACTER DENITRIFICANS; CEREBRAL VENTRICULITIS; GRAM-NEGATIVE BACTERIAL INFECTIONS; TREATMENT OUTCOME;

ACHROMOBACTER DENITRIFICANS; ADULT; ANTI-BACTERIAL AGENTS; CARBAPENEMS; CEREBRAL VENTRICULITIS; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; TREATMENT OUTCOME;

EID: 84929660615     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcs048     Document Type: Article

References (16)

1. Shigeta S, Yasunaga Y, Honzumi K, Okamura H, Kumata R, Endo S. Cerebral ventriculitis associated with Achromobacter xylosoxidans. J Clin Pathol 1978; 31:156-61.
2. Namnyak SS, Holmes B, Fathalla SE. Neonatal meningitis caused by Achromobacter xylosoxidans. J Clin Microbiol 1985; 22:470-1.
3. Sepkowitz DV, Bostic DE, Maslow MJ. Achromobacter xylosoxidans meningitis: case report and review of the literature. Clin Pediatr 1987; 26:483-5.
4. D'Amato RF, Salemi M, Mathews A, Cleri DJ, Reddy G. Achromobacter xylosoxidans (Alcaligenes xylosoxidans subsp. subsp. Xylosoxidans) meningitis associated with a gunshot wound. J Clin Microbiol 1988; 26:2425-6.
5. Ramos JM, Fernandez-Roblas R, Garcia-Ruiz P, Soriano F. Meningitis caused by Alcaligenes (Achromobacter) xylosoxidans associated with epidural catheter. Infection 1995; 23:395-6.
6. Espinoza-Gomez F, Newton-Sanchez OA, Melnkov V, Virgen-Gonzalez O, Unrau J. Meningitis caused by Alcaligenes xylosoxidans in a patient with HIV/AIDS. Brazil J Infect Dis 2007; 11:603-4.
7. Manjra AI, Moosa A, Bhamjee A. Fatal neonatal meningitis and ventriculitis caused by multiresistant Achromobacter xylosoxidans. S Afr Med J 1989; 76:571-3.
8. Almuzara M, Limansky A, Ballerini V, Galanternik L, Farmiglietti A, Vay C. In vitro susceptibility of Achromobacter spp. Isolates: comparison of disk diffusion, Etest and agar dilution methods. Int J Antimicrob Agents 2010; 35:68-71.
9. Mandell WF, Garvey FJ, Neu HC. Achromobacter xylosoxidans bacteremia. Rev Infect Dis 1987; 9:1001-5.
10. van de Beek D, Drake JM, Tunkel AR. Nosocomial bacterial meningitis. N Engl J Med 2010; 162:146-54.
11. Horiuchi M, Kimura M, Tokumura M, Hasebe N, Arai T, Abe K. Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with b-lactam antibiotics. Toxicology 2006; 222: 114-24.
12. Gelfand MS, Cleveland KO, Mazumder SA. Successful treatment with doripenem and tobramycin of ventriculitis due to imipenem- and meropenem-resistant Pseudomonas aeruginosa. J Antimicrob Chemother 2009; 63:1297-9.
13. Tunkel AR, Kaufman BA. Cerebrospinal fluid shunt infections. In: Mandell GL, Bennett JE, Dolin R, eds, Mandell, Douglas, and Bennett's Principles and Practices of Infectious Diseases. Philadelphia, PA, Elsevier Inc., 2005:1126-32.
14. Arroyo JC, Jordan W, Lema MW, Brown A. Diversity of plasmids in Achromobacter xylosoxidans isolates responsible for a seemingly common-source nosocomial outbreak. J Clin Microbiol 1987; 25:1952-5.
15. Matthews SJ, Lancaster JW. Doripenem monohydrate, a broad-spectrum carbapenem antibiotic. Clin Ther 2009; 31: 42-63.
16. Margetis K, Dimaraki E, Charkoftaki G, Vryonis E, Markantonis S, Boutos N, et al. Penetration of intact blood-brain barrier by doripenem. Antimicrob Agents Chemother 2011; 55:3637-8.